Suppr超能文献

玻璃体切除术后的局部麻醉

Topical anesthesia in posterior vitrectomy.

作者信息

Yepez J, Cedeño de Yepez J, Arevalo J F

机构信息

Clinica de Ojos de Maracaibo, Clinica Oftalmologica Centro Caracas, Venezuela.

出版信息

Retina. 2000;20(1):41-5. doi: 10.1097/00006982-200001000-00008.

Abstract

PURPOSE

To evaluate the efficacy of topical anesthesia as an alternative to peribulbar or retrobulbar anesthesia in posterior vitrectomy procedures.

METHODS

Posterior vitrectomy using topical anesthesia (4% lidocaine drops) was performed prospectively in 134 eyes (134 patients) with various vitreoretinal diseases, including severe proliferative diabetic retinopathy (n = 69), vitreous hemorrhage (n = 12), rhegmatogenous retinal detachments (n = 11), epiretinal membranes (n = 10), macular holes (n = 7), dislocated crystalline lens or intraocular lens (n = 6), giant retinal tears (n = 5), intraocular foreign bodies (n = 3), trauma (n = 3), endophthalmitis (n = 3), subfoveal choroidal neovascular membrane (n = 3), and neovascular glaucoma (n = 2). In 26 (19.4%) eyes, posterior vitrectomy was combined with a scleral buckling procedure, and in 84 (62.6%) eyes, argon laser photocoagulation was performed. Preoperative and intraoperative sedation of varying degrees was necessary. Subjective pain and discomfort were graded from 1 (no pain or discomfort) to 4 (severe pain and discomfort).

RESULTS

All patients had grade 1 pain and discomfort during most of the procedure. All patients had grade 2 (mild) pain and discomfort during pars plana sclerotomies, external bipolar cautery, and conjunctival closure. The average amount of 4% lidocaine drops needed during each procedure was 0.5 mL. No patient required additional retrobulbar, peribulbar, or sub-Tenon anesthesia.

CONCLUSIONS

This technique avoids the risk of globe perforation, retrobulbar hemorrhage, and prolonged postoperative akinesia of the eye. With appropriate case selection, topical anesthesia is a safe and effective alternative to peribulbar or retrobulbar anesthesia in three-port pars plana vitrectomy procedures.

摘要

目的

评估表面麻醉作为球周或球后麻醉替代方法在玻璃体切除术中的疗效。

方法

对134例(134只眼)患有各种玻璃体视网膜疾病的患者进行前瞻性表面麻醉(4%利多卡因滴眼液)下的玻璃体切除术,这些疾病包括重度增殖性糖尿病视网膜病变(69例)、玻璃体积血(12例)、孔源性视网膜脱离(11例)、视网膜前膜(10例)、黄斑裂孔(7例)、晶状体或人工晶状体脱位(6例)、巨大视网膜裂孔(5例)、眼内异物(3例)、外伤(3例)、眼内炎(3例)、黄斑下脉络膜新生血管膜(3例)和新生血管性青光眼(2例)。26只眼(19.4%)的玻璃体切除术联合巩膜扣带术,84只眼(62.6%)进行了氩激光光凝。术前和术中需要不同程度的镇静。主观疼痛和不适程度从1级(无疼痛或不适)到4级(严重疼痛和不适)进行分级。

结果

所有患者在手术的大部分时间内疼痛和不适程度为1级。所有患者在睫状体扁平部巩膜切开、外路双极电凝和结膜缝合时疼痛和不适程度为2级(轻度)。每次手术所需4%利多卡因滴眼液的平均量为0.5 mL。没有患者需要额外的球后、球周或球结膜下麻醉。

结论

该技术避免了眼球穿孔、球后出血和术后长时间眼球运动障碍的风险。经过适当的病例选择,在三通道睫状体扁平部玻璃体切除术中,表面麻醉是球周或球后麻醉安全有效的替代方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验